Ph.D Student
Us
Conducted my Ph.D study in Dr. Michael Brattain Lab.Publications:1. Wang J, Ko, TYC, Gong J and Brattain MG. 2004. Autocrine and exogeneous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity. Journal Biological Chemistry. 279(38): 40237-44.2.Gong J, Ammananchi S, Ko, TC and Brattain MG, 2003. Transforming growth factor beta1 increase the stability of p21/waf1/cip1 protein and inhibits CDK2 kinase activity in human colon cancer FET cells. Cancer Research, Jun.15, 63 (12): 3340-6.3. DanHui Wang, LuZhe Sun, Elizabeth Zborowska, James K.V.W, JianGen Gong, Janaki Verraraghavan and Michael G. Brattain. 1999. Control of type II Transforming Growth Factor-beta Receptor statement by Integrin Ligation. Journal of Biological Chemistry. 274, 12840-12847.4. Jenny Wang, JianGen Gong, Tien C. Ko, Xiao-Fan Wang, and Michael G. Brattain. 1999. Autocrine Negative TGF-beta1 Controls the Cell Cycle by Inhibition of Cyclin A/CDK2 complexes through a p21 Mediated Mechanism. Journal of Biological Chemistry. 5. JianGen Gong, Tien C. Ko, and Michael G. Brattain. 1998. Disruption of Fibronectin Binding to the Integrin alpha5 by alpha 5 Monoclonal Antibody Stimulates the DNA synthesis and Cyclin Dependent Kinase through Extracellular Signal-Regulated Kinases. Journal of Biological Chemistry. 273, 1662-1669.6. JianGen Gong, DanHui Wang, James K.V.Willson, Elizabeth Zborowska, LuZhe Sun, and Michael G. Brattain. 1997. Role of alpha5beta1 Integrin in Determining Malignant Properties in Colon Carcinoma Cells. Cell Growth & Differentiation 8: 83-90.7. DanHui Wang, Guo-hao Zhou, Thomas M. Birkenmeier, JianGen Gong, LuZhe Sun, and Michael G. Brattain. 1995. Autocrine Transforming Growth Factor beta1 Modulates the statement of Integrin alpha5beta1 in Human Colon Carcinoma FET Cells. Journal of Biological Chemistry 270, 14154-14159